The Ahmedabad-based Intas Pharmaceuticals Ltd on Tuesday said, it has filed the Draft Red Herring Prospectus with the SEBI for an IPO of its equity shares of face value of Rs 10 each, comprising a fresh issue of shares aggregating up to Rs 425 crore, and an offer for sale of 5.8 million shares by Mozart Ltd.
The issue will be made through a 100 per cent book-building process wherein not more than 50 per cent of the issue will be allocated on a proportionate basis to qualified institutional buyers, 15 per cent to non-institutional bidders and 35 per cent to retail individual bidders, a company release said here.
Kotak Mahindra Capital Company Ltd and Morgan Stanley India Company Private Ltd are the book running lead managers to the issue.